Prometheus Biosciences, Inc. (NASDAQ:RXDX) Given Consensus Rating of "Hold" by Analysts
Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX – Get Rating) have been assigned a consensus recommendation of “Hold” from the eleven ratings firms that are currently covering the company, Marketbeat reports. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price […]